Clinical Trial Update: Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating etanercept for idiopathic pneumonia syndrome after stem cell transplantation completed; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pneumonia Syndrome
• Pneumonia

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Pneumonia, Idiopathic Pneumonia Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2016-05-16